Follow
CELLECTIS
Euronext Growth Paris (France)
Cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited T-cells (UCART)
Sector:
HEALTH CARE
>
Biotechnology
Pharmaceuticals And Biotechnology
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
ALCLS
FR0010425595
Euronext Growth Paris
France (FR)
Details of share in CELLECTIS with ticker ALCLS
Status
Active
Order book id
Amount of instruments
42 489 133
Par value
Market cap
Currency
EUR
Segment
Euronext Growth public offering
Terms
People
André Choulika
CEO
André Choulika
Chairman of the board
Eric Dutang
Board member
Simon Harnest
Board member
Company Details
Sector
HEALTH CARE

Address
8 RUE DE LA CROIX JARRY
Zip code
75013
City/district
PARIS 13
Country
France (FR)
Registration number
428859052
LEI code
969500BXX0YXS81JAR73
First trade date
06 Feb 2007
Registration date
01 Jan 2000
Short name
CELLECTIS

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date